Skip to content

MIRM

Mirum Pharmaceuticals, Inc.

Stock

$82.93−0.99 (−1.18%)Close Oct 2, 2026

Free cash flow, 2025
$55M
YoY, 2025
+488.0%

Free cash flow

Free cash flow by fiscal year

PeriodFree cash flowYoY
2025$55M+488.0%
2024$9.3M—
2023−$71M—
2022−$120M—
2021−$133M—
2020−$89M—
2019−$40M—